Published in Am J Hosp Pharm on September 01, 1993
Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol (1999) 2.23
Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients. Drug Metab Dispos (2000) 1.67
Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients. Antimicrob Agents Chemother (1993) 1.65
Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res (1999) 1.54
Reproducibility of three different methods of measuring baroreflex sensitivity in normal subjects. Clin Sci (Lond) (1998) 1.43
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol (1996) 1.41
Response of hormone refractory prostate cancer to lycopene. J Urol (2001) 1.40
A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1992) 1.37
Escherichia coli DNA helicase II is active as a monomer. J Biol Chem (1999) 1.32
Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions. Drug Metab Dispos (1997) 1.30
Validity of bioelectric impedance for body composition assessment in children. J Appl Physiol (1985) (1989) 1.27
Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains. J Antimicrob Chemother (1991) 1.18
Quinolone resistance in veterinary isolates of Salmonella. J Antimicrob Chemother (1994) 1.16
Detection of small changes in body composition by dual-energy x-ray absorptiometry. Am J Clin Nutr (1993) 1.14
Resistance exercise training is associated with decreases in serum low-density lipoprotein cholesterol levels in premenopausal women. Arch Intern Med (1993) 1.06
Inactivation of DNA mismatch repair by increased expression of yeast MLH1. Mol Cell Biol (2001) 1.03
Transrectal ultrasound and biopsy in the early diagnosis of prostate cancer. Cancer Control (2001) 1.01
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy. Clin Cancer Res (2000) 1.00
Mechanism of action of lomefloxacin. Antimicrob Agents Chemother (1990) 0.97
Articular changes in the knee of the adult rat after prolonged immobilization in extension. Clin Orthop Relat Res (1968) 0.96
A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys (2001) 0.96
Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors. J Clin Oncol (1999) 0.95
Cartilage changes after experimental relief of contact in the knee joint of the mature rat. Clin Orthop Relat Res (1969) 0.95
The Structure of the Upper End of the Humerus with Reference to Osteoporotic Changes in Senescence Leading to Fractures. Can Med Assoc J (1963) 0.93
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks. Ann Oncol (2001) 0.91
Shelf-lives and factors affecting the stability of morphine sulphate and meperidine (pethidine) hydrochloride in plastic syringes for use in patient-controlled analgesic devices. J Clin Pharm Ther (1994) 0.90
Nutrients, body composition and exercise are related to change in bone mineral density in premenopausal women. J Nutr (1995) 0.89
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol (1999) 0.89
Skeletal complications in a series of human renal allografts. JAMA (1969) 0.89
Long-term metabolic effects of urinary diversion: a comparison of myelomeningocele patients managed by clean intermittent catheterization and urinary diversion. J Urol (1992) 0.88
Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients. Eur J Clin Pharmacol (1987) 0.88
Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography. J Chromatogr (1985) 0.86
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies. Cancer Chemother Pharmacol (2008) 0.84
Coronary sinus diverticulum containing posteroseptal accessory pathway. Heart (2001) 0.83
Biomarkers associated with prostate cancer progression. J Cell Biochem Suppl (1994) 0.83
In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6. Br J Cancer (1999) 0.82
Separation of massive avascular osteocartilaginous fragment of femoral condyle following renal transplantation. Report of two cases. J Bone Joint Surg Am (1970) 0.82
Comparative pharmacology of the novel cyclopropylpyrroloindole-prodrug carzelesin in mice, rats, and humans. Cancer Res (1998) 0.82
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors. J Clin Oncol (1998) 0.80
Sleep apnoea/hypopnoea syndrome: a potential cause of graft failure following heart transplantation. Eur J Cardiothorac Surg (1998) 0.79
Prediction of body composition in premenopausal females from dual-energy X-ray absorptiometry. J Appl Physiol (1985) (1993) 0.79
Fully automated high-performance liquid chromatographic method for the determination of carzelesin (U-80,244) and metabolites (U-76,073 and U-76,074) in human plasma. J Chromatogr (1994) 0.79
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study. Cancer Chemother Pharmacol (1998) 0.79
Recent advances in the treatment of prostate cancer. Ann Oncol (1999) 0.79
Eustachian tube blockage and Meniere's disease. Arch Otolaryngol (1977) 0.78
Bladder cancer. Curr Opin Oncol (2000) 0.78
Practical techniques for assessing body composition in middle-aged and older adults. Med Sci Sports Exerc (1995) 0.78
Preemptive analgesia for prostatectomy. JAMA (1998) 0.78
Alternative dosing schedules for irinotecan. Oncology (Williston Park) (1998) 0.77
Cardiac monitoring during exercise tests in the horse. 2. Heart rate responses to exercise. Aust Vet J (1976) 0.76
Interaction between sildenafil and HIV-1 combination therapy. Lancet (1999) 0.76
Evaluation of the pharmacokinetic interaction between cimetidine or famotidine and cyclosporine in healthy men. Ann Pharmacother (1995) 0.76
Effect of an enteral nutrient formula on sustained-release theophylline absorption. Ther Drug Monit (1989) 0.75
Ureteroscopic management of patients with upper tract transitional cell carcinoma. Urol Clin North Am (2000) 0.75
Assessing symptom control in palliative home care. Can Fam Physician (1984) 0.75
Pamihall stain. Acta Cytol (1977) 0.75
BRAYTON HOWARD RANSOM. Science (1925) 0.75
Bone changes in patients with renal transplants. J Am Med Womens Assoc (1968) 0.75
THE HELMINTHOLOGICAL SOCIETY OF WASHINGTON. Science (1911) 0.75
THE HELMINTHOLOGICAL SOCIETY OF WASHINGTON. Science (1911) 0.75
Effect of sucralfate on theophylline absorption in healthy volunteers. Clin Pharm (1988) 0.75
Comparison of harmonic mean versus arithmetic mean clearance values. J Pharm Sci (1986) 0.75
Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias. Leukemia (1998) 0.75
Thoracoabdominal radical nephrectomy: is a postoperative thoracostomy tube necessary? Urology (2000) 0.75
Complications at the ankle and the midtarsal joints following subtalar arthrodesis by the Gallie method: a case report. Clin Orthop Relat Res (1963) 0.75
Exposure of intestinal segments to hemiacidrin: analysis of metabolic and histological effects using a rat model. J Urol (1994) 0.75
Mechanism of ammonium transport: inhibition by potassium and barium. J Urol (1992) 0.75
A post-mortem analysis of degenerative changes in the hip, knee and great toe joints. Gerontol Clin (Basel) (1969) 0.75
Service quality in the health care industry: how are hospitals evaluated by the general public? J Hosp Mark (1992) 0.75
Bioavailability of oral sustained-release capsules of theophylline. Ann Allergy (1979) 0.75
Cardiac monitoring during exercise tests in the horse. 1. Magnetic tape recording in preference to radio-telemetry. Aust Vet J (1975) 0.75
The hematological responses of rats exposed to conditions of simulated microgravity and acute exercise. Aviat Space Environ Med (1998) 0.75
Cardiac monitoring during exercise tests in the horse. 3. Changes in the electrocardiogram during and after exercise. Aust Vet J (1976) 0.75